James C. Mulloy, PhD

Co-Leader, Hematological Malignancy Program

Academic Affiliations

Professor, UC Department of Pediatrics

Phone 513-636-1844

Fax 513-636-3768

Email james.mulloy@cchmc.org

BA: St. Anselm College, Manchester, NH, 1986.

MS: Rutgers University-University of Medicine and Dentistry, New Brunswick, NJ, 1989.

PhD: Rutgers University-University of Medicine and Dentistry, New Brunswick, NJ, 1992.

Suppression of IgE-Mediated Disease by Polyclonal Rapid Desensitization. Co-Investigator. National Institutes of Health/National Institute of Allergy and Infectious Diseases. Jul 2014-Jun 2019.

Instructive role of MLL fusion proteins in lineage determination and Leukemogenesis. Co-Principal Investigator. National Institutes of Health/National Cancer Institute. Mar 2017-Feb 2022. R01 CA215504-01.

Leukemia stem cell polarity and differentiation therapy. Co-Principal Investigator. National Institutes of Health/National Cancer Institute. Sep 2017-Aug 2022. R01 CA204895-01A1.

Suppression of IgE-Mediated Disease by Polyclonal Rapid Desensitization. Co-Investigator. National Institutes of Health/National Institute of Allergy and Infectious Diseases. Jul 2014-Jun 2019.

The role of hedgehog signaling in gastric tissue homeostasis and disease. Co-Investigator. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases. Sep 2016-Aug 2021. 5R01DK083402-05.

Molecular and cellular mechanisms of chronic myelomonocytic leukemia (CMML). Co-Investigator. National Institutes of Health/National Cancer Institute. Mar 2017-Feb 2022. 5R01CA152108-05.